Biopolis, S.L. is a leading biotechnology company based in Valencia (Spain) offering contract research and manufacturing. The company is classified as an SME. Our core competences are the isolation, selection, design, characterization, validation and production of microorganisms and cellular metabolites with applications in agrifood, pharmaceutical and chemical industries. Prototype projects are the selection, validation and production of starters and probiotics, the selection and production of enzymes, the identification, characterization and process development of functional ingredients, or the overexpression of recombinant protein in microbial systems and the design of novel processes based on microbial and enzymatic catalysis, just to mention some.
BIOP will direct the development of the bioreactor based on the metabolically engineered R. eutropha for PHA production from CO2 and H2.
BIOP will be responsible for the optimisation of the metabolic engineering and operating conditions of the engineered strain and for the bioreactor related operating strategies at TRL 3-4. BIOP will also actively participate in integrate system analysis and impact studies.
This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 760994.
The content of this publication is the sole responsibility of the authors. The European Commission or its services cannot be held responsible for any use that may be made of the information it contains.